Financhill
Sell
50

CADL Quote, Financials, Valuation and Earnings

Last price:
$5.26
Seasonality move :
8.7%
Day range:
$4.97 - $5.32
52-week range:
$4.25 - $14.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1,949.18x
P/B ratio:
3.60x
Volume:
1.4M
Avg. volume:
709.2K
1-year change:
18.74%
Market cap:
$288.8M
Revenue:
--
EPS (TTM):
-$0.56

Earnings Data

Next earnings date for CADL
Mar 12
2026
Most recent earnings per share
-$0.21
Missed by $0.04
(Nov 13/2025)
Consensus Estimate
-$0.17
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CADL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/12/2026 Q4 -- -- -- -$0.25 --
11/13/2025 Q3 -- -- -$0.21 -$0.17 -$0.04
08/14/2025 Q2 -- -- -$0.09 -$0.18 $0.08
05/15/2025 Q1 -- -- $0.13 -$0.24 $0.37
03/13/2025 Q4 -- -- -$0.40 -$0.23 -$0.17
11/14/2024 Q3 -- -- -$0.33 -- --
08/13/2024 Q2 -- -- -$0.74 -- --
05/14/2024 Q1 -- -- -$0.28 -- --
03/28/2024 Q4 -- -- -$0.38 -- --
11/09/2023 Q3 -- -- -$0.29 -- --
08/10/2023 Q2 -- -- -$0.33 -$0.37 $0.04
05/11/2023 Q1 -- -- -$0.30 -- --
03/30/2023 Q4 -- $31K -$0.18 -- --
11/10/2022 Q3 -- $31K -$0.30 -- --
08/05/2022 Q2 -- $31K -$0.14 -- --
05/12/2022 Q1 -- $31K -$0.03 -- --
03/29/2022 Q4 -- $31K $0.05 -- --
11/12/2021 Q3 -- $31K -$0.56 -- --
09/08/2021 Q2 -- $31K -$0.60 -- --
03/31/2021 Q1 -- $31K -$0.15 -- --
12/31/2020 Q4 -- $31K -$0.56 -- --
09/30/2020 Q3 -- $31K -$0.09 -- --
06/30/2020 Q2 -- $31K -$0.15 -- --
03/31/2020 Q1 -- $31K -$0.06 -- --

Candel Therapeutics, Inc. Earnings Questions

  • How Much did Candel Therapeutics, Inc. Generate in Revenue Last Quarter?

    Candel Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Candel Therapeutics, Inc. Beat Earnings Last Quarter?

    Candel Therapeutics, Inc. announced earnings per share of -$0.21 which represents a miss of analyst forecast a -$0.17 per share.

  • Is Candel Therapeutics, Inc. Profitable?

    Candel Therapeutics, Inc. reported -$195K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Candel Therapeutics, Inc. EPS Next Year?

    Candel Therapeutics, Inc.'s earnings are forecast to decrease from -$1.74 per share to -$1.14 per share next year representing a decrease of -76.46%.

  • When is Candel Therapeutics, Inc.'s Earnings Date?

    Candel Therapeutics, Inc.'s next earnings date is March 12, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 38x

Buy
63
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 40x

Alerts

Buy
54
SMX alert for Dec 5

SMX (Security Matters) Plc [SMX] is up 117.4% over the past day.

Sell
15
HOV alert for Dec 5

Hovnanian Enterprises, Inc. [HOV] is up 1.62% over the past day.

Buy
67
NUTX alert for Dec 5

Nutex Health, Inc. [NUTX] is up 1.03% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock